PTGS2 and neoplasm: It is therefore plausible to speculate that the substantial VEGF-induced release of PGH2 that has been observed in tumour endothelial cells [203] may happen not only as a consequence of VEGF induction of COX-2 [203], but also because prostacyclin synthetase in the endothelial cells is simultaneously inhibited.